EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance

Michael C Brown, Justin T Low, Michelle L Bowie, David M Ashley

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci186547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Michael C Brown und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Membrane Proteins, Heme Oxygenase-1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cyclic GMP-AMP synthase/stimulator of interferon genes (cGAS/STING) pathway is a critical driver of type I interferon (IFN-I) and antitumor CD8 + T cell responses after radiotherapy (RT). In this issue of the JCI , two reports describe mechanisms that restrained STING signaling and abrogated antitumor immunity after RT. Wen, Wang, and colleagues discovered that IFN-I mediated the induction of YTHDF1, an RNA N 6 -methyladenosine–binding protein, in DCs after RT promoted cathepsin-mediated STING degradation. Zhang, Deng, Wu, and colleagues discovered that hemeoxygenase 1 (HO-1) was induced and proteolytically cleaved after RT to suppress cGAS cytoplasmic export as well as STING oligomerization at the ER. Blocking the STING-suppressive functions of YTHDF1 and HO-1, respectively, improved antitumor T cell immunity and tumor control after RT. Together, these studies support the development of clinical avenues to sustain STING signaling during RT, a standard treatment for approximately 50% of malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsHeme Oxygenase-1HumansAnimalsMiceSignal TransductionRadiation ToleranceNucleotidyltransferasesCD8-Positive T-LymphocytesNeoplasmsInterferon Type IRNA-Binding ProteinsSTING Protein

Substanzen

Membrane ProteinsHeme Oxygenase-1NucleotidyltransferasesInterferon Type IRNA-Binding ProteinsSting1 protein, mouseSTING ProteinSTING1 protein, humanHmox1 protein, mouse

Förderung

  • NCI NIH HHS

Zitieren

APA

Brown, M. C., Low, J. T., Bowie, M. L., & Ashley, D. M. (2024). Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance. Journal of Clinical Investigation. https://doi.org/10.1172/jci186547

Vancouver

Brown MC, Low JT, Bowie ML, Ashley DM. Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance. Journal of Clinical Investigation. 2024. doi:10.1172/jci186547

BibTeX
@article{Brown2024,
  author = {Brown, Michael C and Low, Justin T and Bowie, Michelle L and Ashley, David M},
  title = {Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci186547}
}
Kostenlos starten →